nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—CYP2C9—Donepezil—Alzheimer's disease	0.39	1	CbGbCtD
Cyclizine—Hepatitis cholestatic—Memantine—Alzheimer's disease	0.0188	0.0361	CcSEcCtD
Cyclizine—Altered state of consciousness—Memantine—Alzheimer's disease	0.0164	0.0315	CcSEcCtD
Cyclizine—Blister—Rivastigmine—Alzheimer's disease	0.0103	0.0198	CcSEcCtD
Cyclizine—Apnoea—Memantine—Alzheimer's disease	0.00893	0.0172	CcSEcCtD
Cyclizine—Speech disorder—Memantine—Alzheimer's disease	0.0088	0.0169	CcSEcCtD
Cyclizine—Apnoea—Rivastigmine—Alzheimer's disease	0.00874	0.0168	CcSEcCtD
Cyclizine—Speech disorder—Rivastigmine—Alzheimer's disease	0.00861	0.0166	CcSEcCtD
Cyclizine—Dyskinesia—Memantine—Alzheimer's disease	0.00806	0.0155	CcSEcCtD
Cyclizine—Dyskinesia—Rivastigmine—Alzheimer's disease	0.00788	0.0152	CcSEcCtD
Cyclizine—Urinary retention—Galantamine—Alzheimer's disease	0.00743	0.0143	CcSEcCtD
Cyclizine—Depressed level of consciousness—Memantine—Alzheimer's disease	0.00731	0.0141	CcSEcCtD
Cyclizine—Thrombophlebitis—Memantine—Alzheimer's disease	0.00635	0.0122	CcSEcCtD
Cyclizine—Dermatitis bullous—Donepezil—Alzheimer's disease	0.00633	0.0122	CcSEcCtD
Cyclizine—Hepatic function abnormal—Memantine—Alzheimer's disease	0.00629	0.0121	CcSEcCtD
Cyclizine—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.00621	0.0119	CcSEcCtD
Cyclizine—Disorientation—Memantine—Alzheimer's disease	0.00615	0.0118	CcSEcCtD
Cyclizine—Urinary retention—Donepezil—Alzheimer's disease	0.00576	0.0111	CcSEcCtD
Cyclizine—Dermatitis bullous—Memantine—Alzheimer's disease	0.00575	0.0111	CcSEcCtD
Cyclizine—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00569	0.0109	CcSEcCtD
Cyclizine—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.00563	0.0108	CcSEcCtD
Cyclizine—Hepatitis—Galantamine—Alzheimer's disease	0.0054	0.0104	CcSEcCtD
Cyclizine—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00531	0.0102	CcSEcCtD
Cyclizine—Urinary retention—Memantine—Alzheimer's disease	0.00523	0.01	CcSEcCtD
Cyclizine—Urinary retention—Rivastigmine—Alzheimer's disease	0.00511	0.00983	CcSEcCtD
Cyclizine—Eye disorder—Galantamine—Alzheimer's disease	0.00505	0.00971	CcSEcCtD
Cyclizine—Mental disorder—Galantamine—Alzheimer's disease	0.00473	0.0091	CcSEcCtD
Cyclizine—Bronchospasm—Memantine—Alzheimer's disease	0.00467	0.00898	CcSEcCtD
Cyclizine—Tension—Galantamine—Alzheimer's disease	0.00462	0.00887	CcSEcCtD
Cyclizine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00457	0.00879	CcSEcCtD
Cyclizine—Nervousness—Galantamine—Alzheimer's disease	0.00457	0.00878	CcSEcCtD
Cyclizine—Muscle spasms—Galantamine—Alzheimer's disease	0.00452	0.00869	CcSEcCtD
Cyclizine—Vision blurred—Galantamine—Alzheimer's disease	0.00443	0.00852	CcSEcCtD
Cyclizine—Tremor—Galantamine—Alzheimer's disease	0.00441	0.00847	CcSEcCtD
Cyclizine—Agitation—Galantamine—Alzheimer's disease	0.00432	0.00831	CcSEcCtD
Cyclizine—Hepatitis—Donepezil—Alzheimer's disease	0.00419	0.00805	CcSEcCtD
Cyclizine—Drowsiness—Rivastigmine—Alzheimer's disease	0.00414	0.00797	CcSEcCtD
Cyclizine—Convulsion—Galantamine—Alzheimer's disease	0.00408	0.00783	CcSEcCtD
Cyclizine—Hypertension—Galantamine—Alzheimer's disease	0.00406	0.00781	CcSEcCtD
Cyclizine—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00401	0.0077	CcSEcCtD
Cyclizine—Agranulocytosis—Memantine—Alzheimer's disease	0.00395	0.0076	CcSEcCtD
Cyclizine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00392	0.00753	CcSEcCtD
Cyclizine—Hepatitis—Memantine—Alzheimer's disease	0.0038	0.00731	CcSEcCtD
Cyclizine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00377	0.00724	CcSEcCtD
Cyclizine—Chills—Donepezil—Alzheimer's disease	0.00376	0.00722	CcSEcCtD
Cyclizine—Tachycardia—Galantamine—Alzheimer's disease	0.00375	0.0072	CcSEcCtD
Cyclizine—Connective tissue disorder—Memantine—Alzheimer's disease	0.00374	0.00718	CcSEcCtD
Cyclizine—Skin disorder—Galantamine—Alzheimer's disease	0.00373	0.00717	CcSEcCtD
Cyclizine—Hepatitis—Rivastigmine—Alzheimer's disease	0.00372	0.00715	CcSEcCtD
Cyclizine—Mental disorder—Donepezil—Alzheimer's disease	0.00367	0.00705	CcSEcCtD
Cyclizine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00366	0.00703	CcSEcCtD
Cyclizine—Erythema—Donepezil—Alzheimer's disease	0.00365	0.00701	CcSEcCtD
Cyclizine—Hypotension—Galantamine—Alzheimer's disease	0.00359	0.0069	CcSEcCtD
Cyclizine—Tension—Donepezil—Alzheimer's disease	0.00358	0.00688	CcSEcCtD
Cyclizine—Eye disorder—Memantine—Alzheimer's disease	0.00355	0.00683	CcSEcCtD
Cyclizine—Nervousness—Donepezil—Alzheimer's disease	0.00354	0.00681	CcSEcCtD
Cyclizine—Muscle spasms—Donepezil—Alzheimer's disease	0.00351	0.00674	CcSEcCtD
Cyclizine—Eye disorder—Rivastigmine—Alzheimer's disease	0.00348	0.00668	CcSEcCtD
Cyclizine—Insomnia—Galantamine—Alzheimer's disease	0.00347	0.00667	CcSEcCtD
Cyclizine—SULT1E1—Biological oxidations—CYP46A1—Alzheimer's disease	0.00347	0.0535	CbGpPWpGaD
Cyclizine—Paraesthesia—Galantamine—Alzheimer's disease	0.00345	0.00663	CcSEcCtD
Cyclizine—Vision blurred—Donepezil—Alzheimer's disease	0.00344	0.0066	CcSEcCtD
Cyclizine—SULT1E1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.00342	0.0528	CbGpPWpGaD
Cyclizine—Tremor—Donepezil—Alzheimer's disease	0.00342	0.00657	CcSEcCtD
Cyclizine—Somnolence—Galantamine—Alzheimer's disease	0.00341	0.00656	CcSEcCtD
Cyclizine—Chills—Memantine—Alzheimer's disease	0.00341	0.00656	CcSEcCtD
Cyclizine—Agitation—Donepezil—Alzheimer's disease	0.00335	0.00644	CcSEcCtD
Cyclizine—Chills—Rivastigmine—Alzheimer's disease	0.00334	0.00642	CcSEcCtD
Cyclizine—Mental disorder—Memantine—Alzheimer's disease	0.00333	0.0064	CcSEcCtD
Cyclizine—Constipation—Galantamine—Alzheimer's disease	0.00328	0.00631	CcSEcCtD
Cyclizine—Mental disorder—Rivastigmine—Alzheimer's disease	0.00326	0.00626	CcSEcCtD
Cyclizine—Tension—Memantine—Alzheimer's disease	0.00325	0.00624	CcSEcCtD
Cyclizine—Erythema—Rivastigmine—Alzheimer's disease	0.00324	0.00622	CcSEcCtD
Cyclizine—Nervousness—Memantine—Alzheimer's disease	0.00322	0.00618	CcSEcCtD
Cyclizine—Tension—Rivastigmine—Alzheimer's disease	0.00318	0.00611	CcSEcCtD
Cyclizine—Convulsion—Donepezil—Alzheimer's disease	0.00316	0.00607	CcSEcCtD
Cyclizine—Hypertension—Donepezil—Alzheimer's disease	0.00315	0.00605	CcSEcCtD
Cyclizine—Nervousness—Rivastigmine—Alzheimer's disease	0.00315	0.00605	CcSEcCtD
Cyclizine—Vision blurred—Memantine—Alzheimer's disease	0.00312	0.006	CcSEcCtD
Cyclizine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00311	0.00598	CcSEcCtD
Cyclizine—Tremor—Memantine—Alzheimer's disease	0.0031	0.00596	CcSEcCtD
Cyclizine—Vision blurred—Rivastigmine—Alzheimer's disease	0.00305	0.00587	CcSEcCtD
Cyclizine—Agitation—Memantine—Alzheimer's disease	0.00304	0.00585	CcSEcCtD
Cyclizine—Tremor—Rivastigmine—Alzheimer's disease	0.00303	0.00583	CcSEcCtD
Cyclizine—Agitation—Rivastigmine—Alzheimer's disease	0.00298	0.00572	CcSEcCtD
Cyclizine—Nervous system disorder—Donepezil—Alzheimer's disease	0.00292	0.00561	CcSEcCtD
Cyclizine—Convulsion—Memantine—Alzheimer's disease	0.00287	0.00551	CcSEcCtD
Cyclizine—Hypertension—Memantine—Alzheimer's disease	0.00286	0.00549	CcSEcCtD
Cyclizine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00283	0.00544	CcSEcCtD
Cyclizine—Convulsion—Rivastigmine—Alzheimer's disease	0.00281	0.00539	CcSEcCtD
Cyclizine—Hypertension—Rivastigmine—Alzheimer's disease	0.0028	0.00537	CcSEcCtD
Cyclizine—Hypotension—Donepezil—Alzheimer's disease	0.00278	0.00534	CcSEcCtD
Cyclizine—Asthenia—Galantamine—Alzheimer's disease	0.00275	0.00529	CcSEcCtD
Cyclizine—Insomnia—Donepezil—Alzheimer's disease	0.00269	0.00517	CcSEcCtD
Cyclizine—Paraesthesia—Donepezil—Alzheimer's disease	0.00267	0.00514	CcSEcCtD
Cyclizine—Ifenprodil—GRIN2B—Alzheimer's disease	0.00266	0.107	CrCbGaD
Cyclizine—Nervous system disorder—Memantine—Alzheimer's disease	0.00265	0.00509	CcSEcCtD
Cyclizine—Somnolence—Donepezil—Alzheimer's disease	0.00265	0.00508	CcSEcCtD
Cyclizine—Tachycardia—Memantine—Alzheimer's disease	0.00264	0.00507	CcSEcCtD
Cyclizine—Skin disorder—Memantine—Alzheimer's disease	0.00262	0.00504	CcSEcCtD
Cyclizine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00259	0.00498	CcSEcCtD
Cyclizine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00258	0.00496	CcSEcCtD
Cyclizine—Skin disorder—Rivastigmine—Alzheimer's disease	0.00257	0.00493	CcSEcCtD
Cyclizine—Pain—Donepezil—Alzheimer's disease	0.00254	0.00489	CcSEcCtD
Cyclizine—Constipation—Donepezil—Alzheimer's disease	0.00254	0.00489	CcSEcCtD
Cyclizine—Dizziness—Galantamine—Alzheimer's disease	0.00254	0.00488	CcSEcCtD
Cyclizine—Hypotension—Memantine—Alzheimer's disease	0.00252	0.00485	CcSEcCtD
Cyclizine—Hypotension—Rivastigmine—Alzheimer's disease	0.00247	0.00475	CcSEcCtD
Cyclizine—Insomnia—Memantine—Alzheimer's disease	0.00244	0.0047	CcSEcCtD
Cyclizine—Paraesthesia—Memantine—Alzheimer's disease	0.00243	0.00466	CcSEcCtD
Cyclizine—Headache—Galantamine—Alzheimer's disease	0.00241	0.00462	CcSEcCtD
Cyclizine—Somnolence—Memantine—Alzheimer's disease	0.0024	0.00462	CcSEcCtD
Cyclizine—Insomnia—Rivastigmine—Alzheimer's disease	0.00239	0.00459	CcSEcCtD
Cyclizine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00237	0.00456	CcSEcCtD
Cyclizine—Urticaria—Donepezil—Alzheimer's disease	0.00236	0.00454	CcSEcCtD
Cyclizine—Somnolence—Rivastigmine—Alzheimer's disease	0.00235	0.00452	CcSEcCtD
Cyclizine—Constipation—Memantine—Alzheimer's disease	0.00231	0.00444	CcSEcCtD
Cyclizine—Pain—Memantine—Alzheimer's disease	0.00231	0.00444	CcSEcCtD
Cyclizine—Constipation—Rivastigmine—Alzheimer's disease	0.00226	0.00434	CcSEcCtD
Cyclizine—Pain—Rivastigmine—Alzheimer's disease	0.00226	0.00434	CcSEcCtD
Cyclizine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00219	0.00421	CcSEcCtD
Cyclizine—Urticaria—Memantine—Alzheimer's disease	0.00215	0.00413	CcSEcCtD
Cyclizine—Asthenia—Donepezil—Alzheimer's disease	0.00214	0.0041	CcSEcCtD
Cyclizine—Pruritus—Donepezil—Alzheimer's disease	0.00211	0.00405	CcSEcCtD
Cyclizine—Urticaria—Rivastigmine—Alzheimer's disease	0.0021	0.00404	CcSEcCtD
Cyclizine—SULT1E1—Biological oxidations—MAOB—Alzheimer's disease	0.00207	0.0319	CbGpPWpGaD
Cyclizine—Flunarizine—CALM1—Alzheimer's disease	0.002	0.0801	CrCbGaD
Cyclizine—Hypersensitivity—Memantine—Alzheimer's disease	0.00199	0.00383	CcSEcCtD
Cyclizine—Dizziness—Donepezil—Alzheimer's disease	0.00197	0.00378	CcSEcCtD
Cyclizine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00195	0.00374	CcSEcCtD
Cyclizine—Asthenia—Memantine—Alzheimer's disease	0.00194	0.00373	CcSEcCtD
Cyclizine—Pruritus—Memantine—Alzheimer's disease	0.00191	0.00367	CcSEcCtD
Cyclizine—Asthenia—Rivastigmine—Alzheimer's disease	0.0019	0.00364	CcSEcCtD
Cyclizine—Pruritus—Rivastigmine—Alzheimer's disease	0.00187	0.00359	CcSEcCtD
Cyclizine—Headache—Donepezil—Alzheimer's disease	0.00186	0.00358	CcSEcCtD
Cyclizine—HRH1—Monoamine GPCRs—HTR6—Alzheimer's disease	0.0018	0.0278	CbGpPWpGaD
Cyclizine—Dizziness—Memantine—Alzheimer's disease	0.00179	0.00343	CcSEcCtD
Cyclizine—Dizziness—Rivastigmine—Alzheimer's disease	0.00175	0.00336	CcSEcCtD
Cyclizine—Bepridil—CALM1—Alzheimer's disease	0.00174	0.0696	CrCbGaD
Cyclizine—Headache—Memantine—Alzheimer's disease	0.00169	0.00325	CcSEcCtD
Cyclizine—Headache—Rivastigmine—Alzheimer's disease	0.00166	0.00318	CcSEcCtD
Cyclizine—Cyproheptadine—HTR6—Alzheimer's disease	0.00164	0.0655	CrCbGaD
Cyclizine—SULT1E1—Biological oxidations—PTGS1—Alzheimer's disease	0.00157	0.0242	CbGpPWpGaD
Cyclizine—SULT1E1—Biological oxidations—CYP2D6—Alzheimer's disease	0.00154	0.0237	CbGpPWpGaD
Cyclizine—SULT1E1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.00152	0.0234	CbGpPWpGaD
Cyclizine—Trimethaphan—BCHE—Alzheimer's disease	0.00152	0.0607	CrCbGaD
Cyclizine—HRH1—Amine ligand-binding receptors—HTR6—Alzheimer's disease	0.00151	0.0234	CbGpPWpGaD
Cyclizine—CYP2C9—CYP2E1 reactions—CYP2D6—Alzheimer's disease	0.0015	0.0231	CbGpPWpGaD
Cyclizine—CYP2C9—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00139	0.0214	CbGpPWpGaD
Cyclizine—Phenoxybenzamine—CALM1—Alzheimer's disease	0.00135	0.0542	CrCbGaD
Cyclizine—Atomoxetine—HTR6—Alzheimer's disease	0.00127	0.0508	CrCbGaD
Cyclizine—Mianserin—HTR6—Alzheimer's disease	0.00124	0.0496	CrCbGaD
Cyclizine—Reboxetine—SLC6A4—Alzheimer's disease	0.00121	0.0483	CrCbGaD
Cyclizine—Loxapine—HTR6—Alzheimer's disease	0.000985	0.0394	CrCbGaD
Cyclizine—CYP2C9—Xenobiotics—CYP2D6—Alzheimer's disease	0.000927	0.0143	CbGpPWpGaD
Cyclizine—CYP2C9—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000892	0.0138	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—DHCR24—Alzheimer's disease	0.000889	0.0137	CbGpPWpGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000868	0.0134	CbGpPWpGaD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000857	0.0132	CbGpPWpGaD
Cyclizine—Reboxetine—CYP2D6—Alzheimer's disease	0.000847	0.0339	CrCbGaD
Cyclizine—Hydroxyzine—CYP2D6—Alzheimer's disease	0.000831	0.0333	CrCbGaD
Cyclizine—Clozapine—HTR6—Alzheimer's disease	0.000827	0.0331	CrCbGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—INPP5D—Alzheimer's disease	0.000765	0.0118	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CA4—Alzheimer's disease	0.000756	0.0117	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—GAPDHS—Alzheimer's disease	0.000711	0.011	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000704	0.0109	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—GAB2—Alzheimer's disease	0.000692	0.0107	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ATP5A1—Alzheimer's disease	0.000674	0.0104	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—HTR2A—Alzheimer's disease	0.000647	0.00998	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PLD3—Alzheimer's disease	0.000643	0.00992	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—HSD17B10—Alzheimer's disease	0.000616	0.00951	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CYP46A1—Alzheimer's disease	0.000593	0.00915	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ND1—Alzheimer's disease	0.000573	0.00884	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—HTR2A—Alzheimer's disease	0.000544	0.00839	CbGpPWpGaD
Cyclizine—Benzatropine—CYP2D6—Alzheimer's disease	0.000536	0.0215	CrCbGaD
Cyclizine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000526	0.00812	CbGpPWpGaD
Cyclizine—Atomoxetine—SLC6A4—Alzheimer's disease	0.000485	0.0194	CrCbGaD
Cyclizine—Flunarizine—CYP2D6—Alzheimer's disease	0.000485	0.0194	CrCbGaD
Cyclizine—Cyproheptadine—HTR2A—Alzheimer's disease	0.000481	0.0193	CrCbGaD
Cyclizine—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000476	0.00734	CbGpPWpGaD
Cyclizine—Mianserin—SLC6A4—Alzheimer's disease	0.000474	0.019	CrCbGaD
Cyclizine—CYP2C9—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000454	0.00701	CbGpPWpGaD
Cyclizine—Bepridil—CYP2D6—Alzheimer's disease	0.000422	0.0169	CrCbGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.00042	0.00648	CbGpPWpGaD
Cyclizine—Diphenhydramine—PTGS1—Alzheimer's disease	0.000405	0.0162	CrCbGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000385	0.00594	CbGpPWpGaD
Cyclizine—Cinnarizine—CYP2D6—Alzheimer's disease	0.000384	0.0154	CrCbGaD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.00038	0.00586	CbGpPWpGaD
Cyclizine—Loxapine—SLC6A4—Alzheimer's disease	0.000377	0.0151	CrCbGaD
Cyclizine—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	0.000374	0.00577	CbGpPWpGaD
Cyclizine—Atomoxetine—HTR2A—Alzheimer's disease	0.000373	0.0149	CrCbGaD
Cyclizine—SULT1E1—Metabolism—CHAT—Alzheimer's disease	0.000369	0.0057	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—TPI1—Alzheimer's disease	0.000369	0.0057	CbGpPWpGaD
Cyclizine—Prochlorperazine—CYP2D6—Alzheimer's disease	0.000369	0.0148	CrCbGaD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000369	0.00569	CbGpPWpGaD
Cyclizine—Mianserin—HTR2A—Alzheimer's disease	0.000365	0.0146	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.000357	0.00551	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—MAOB—Alzheimer's disease	0.000354	0.00546	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.000348	0.00537	CbGpPWpGaD
Cyclizine—Atomoxetine—CYP2D6—Alzheimer's disease	0.000341	0.0137	CrCbGaD
Cyclizine—SULT1E1—Metabolism—GAPDH—Alzheimer's disease	0.000341	0.00526	CbGpPWpGaD
Cyclizine—Mianserin—CYP2D6—Alzheimer's disease	0.000333	0.0134	CrCbGaD
Cyclizine—SULT1E1—Metabolism—A2M—Alzheimer's disease	0.000329	0.00508	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000318	0.00491	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000312	0.00482	CbGpPWpGaD
Cyclizine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000301	0.00465	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.000298	0.0046	CbGpPWpGaD
Cyclizine—Loxapine—HTR2A—Alzheimer's disease	0.00029	0.0116	CrCbGaD
Cyclizine—SULT1E1—Metabolism—ACHE—Alzheimer's disease	0.000286	0.00442	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—INPP5D—Alzheimer's disease	0.000283	0.00437	CbGpPWpGaD
Cyclizine—Diphenhydramine—CYP2D6—Alzheimer's disease	0.000276	0.011	CrCbGaD
Cyclizine—HRH1—GPCR ligand binding—PYY—Alzheimer's disease	0.000272	0.0042	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—NPS—Alzheimer's disease	0.000268	0.00414	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PTGS1—Alzheimer's disease	0.000268	0.00414	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ENO1—Alzheimer's disease	0.000268	0.00414	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CYP2D6—Alzheimer's disease	0.000263	0.00406	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—APP—Alzheimer's disease	0.00025	0.00385	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—BCHE—Alzheimer's disease	0.000249	0.00385	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.000247	0.00382	CbGpPWpGaD
Cyclizine—Clozapine—HTR2A—Alzheimer's disease	0.000243	0.00974	CrCbGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—Alzheimer's disease	0.00024	0.00371	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—PLCB1—Alzheimer's disease	0.000235	0.00363	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PLCB1—Alzheimer's disease	0.000235	0.00363	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ABCA1—Alzheimer's disease	0.000228	0.00352	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—HTR6—Alzheimer's disease	0.000227	0.0035	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—APP—Alzheimer's disease	0.000223	0.00345	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	0.000223	0.00344	CbGpPWpGaD
Cyclizine—Clozapine—CYP2D6—Alzheimer's disease	0.000222	0.00891	CrCbGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000215	0.00332	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.000211	0.00325	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PPARGC1A—Alzheimer's disease	0.000197	0.00303	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—HMOX1—Alzheimer's disease	0.000196	0.00302	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000194	0.003	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—GAL—Alzheimer's disease	0.000188	0.00291	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—LPL—Alzheimer's disease	0.000179	0.00276	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000178	0.00274	CbGpPWpGaD
Cyclizine—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000174	0.00269	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.00017	0.00262	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	0.000169	0.00261	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	0.000166	0.00256	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000165	0.00255	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000164	0.00252	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.000161	0.00249	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—MTHFR—Alzheimer's disease	0.000161	0.00249	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000156	0.0024	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PYY—Alzheimer's disease	0.000154	0.00237	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CALM1—Alzheimer's disease	0.00015	0.00232	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—APOE—Alzheimer's disease	0.00015	0.00231	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CAV1—Alzheimer's disease	0.000149	0.00229	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—NPY—Alzheimer's disease	0.000148	0.00228	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—IAPP—Alzheimer's disease	0.000147	0.00227	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.000144	0.00223	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000144	0.00222	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CRH—Alzheimer's disease	0.000143	0.0022	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—F2—Alzheimer's disease	0.000142	0.00219	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—AKT1—Alzheimer's disease	0.00014	0.00216	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PYY—Alzheimer's disease	0.00014	0.00215	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—NPS—Alzheimer's disease	0.000135	0.00209	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PPARG—Alzheimer's disease	0.000131	0.00202	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—SST—Alzheimer's disease	0.000129	0.00199	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000128	0.00198	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—INS—Alzheimer's disease	0.000128	0.00198	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000128	0.00197	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.000127	0.00195	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—APP—Alzheimer's disease	0.000126	0.00194	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000125	0.00193	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CDK5—Alzheimer's disease	0.000121	0.00187	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR6—Alzheimer's disease	0.000116	0.0018	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.000115	0.00178	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—NOS3—Alzheimer's disease	0.000112	0.00173	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000109	0.00169	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000107	0.00165	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GAL—Alzheimer's disease	0.000106	0.00164	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PTGS2—Alzheimer's disease	0.000103	0.00159	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GAL—Alzheimer's disease	9.67e-05	0.00149	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	9.58e-05	0.00148	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TTR—Alzheimer's disease	9.43e-05	0.00146	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	9.38e-05	0.00145	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	8.93e-05	0.00138	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—NPY—Alzheimer's disease	8.37e-05	0.00129	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	8.36e-05	0.00129	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CCR5—Alzheimer's disease	8.32e-05	0.00128	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—IAPP—Alzheimer's disease	8.31e-05	0.00128	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PYY—Alzheimer's disease	8.24e-05	0.00127	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CA4—Alzheimer's disease	8.15e-05	0.00126	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—HTR2A—Alzheimer's disease	8.14e-05	0.00126	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CRH—Alzheimer's disease	8.07e-05	0.00125	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	7.96e-05	0.00123	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	7.66e-05	0.00118	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—NPS—Alzheimer's disease	7.65e-05	0.00118	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—NPY—Alzheimer's disease	7.6e-05	0.00117	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IAPP—Alzheimer's disease	7.55e-05	0.00117	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CRH—Alzheimer's disease	7.33e-05	0.00113	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GAB2—Alzheimer's disease	7.3e-05	0.00113	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—SST—Alzheimer's disease	7.3e-05	0.00113	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	7.26e-05	0.00112	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CDK5—Alzheimer's disease	7.15e-05	0.0011	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—F2—Alzheimer's disease	7.14e-05	0.0011	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—APP—Alzheimer's disease	7.11e-05	0.0011	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—NPS—Alzheimer's disease	6.95e-05	0.00107	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PLD3—Alzheimer's disease	6.93e-05	0.00107	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	6.93e-05	0.00107	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PPP3CA—Alzheimer's disease	6.91e-05	0.00107	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR6—Alzheimer's disease	6.88e-05	0.00106	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	6.85e-05	0.00106	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PLCB1—Alzheimer's disease	6.71e-05	0.00104	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	6.64e-05	0.00103	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GAB2—Alzheimer's disease	6.63e-05	0.00102	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—SST—Alzheimer's disease	6.63e-05	0.00102	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	6.49e-05	0.001	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—APP—Alzheimer's disease	6.46e-05	0.000997	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	6.39e-05	0.000987	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CCL2—Alzheimer's disease	6.36e-05	0.000982	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PSENEN—Alzheimer's disease	6.25e-05	0.000964	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ND1—Alzheimer's disease	6.17e-05	0.000953	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APH1A—Alzheimer's disease	6.16e-05	0.000951	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PLCB1—Alzheimer's disease	6.09e-05	0.000941	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	6.04e-05	0.000931	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NCSTN—Alzheimer's disease	6e-05	0.000926	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LRP1—Alzheimer's disease	5.85e-05	0.000903	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GFAP—Alzheimer's disease	5.71e-05	0.000882	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GAL—Alzheimer's disease	5.71e-05	0.000882	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.52e-05	0.000852	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—AKT1—Alzheimer's disease	5.16e-05	0.000797	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—A2M—Alzheimer's disease	5.03e-05	0.000777	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	5.01e-05	0.000774	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PRKCG—Alzheimer's disease	4.96e-05	0.000766	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PSEN2—Alzheimer's disease	4.88e-05	0.000753	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.76e-05	0.000734	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CCR5—Alzheimer's disease	4.7e-05	0.000726	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR2A—Alzheimer's disease	4.6e-05	0.00071	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PRKCG—Alzheimer's disease	4.51e-05	0.000696	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NPY—Alzheimer's disease	4.49e-05	0.000693	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IAPP—Alzheimer's disease	4.46e-05	0.000688	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.33e-05	0.000668	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CRH—Alzheimer's disease	4.33e-05	0.000668	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCR5—Alzheimer's disease	4.27e-05	0.000659	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR2A—Alzheimer's disease	4.18e-05	0.000645	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NPS—Alzheimer's disease	4.1e-05	0.000633	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PPP3CA—Alzheimer's disease	4.08e-05	0.00063	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—F2—Alzheimer's disease	4.04e-05	0.000623	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTK2B—Alzheimer's disease	4.03e-05	0.000621	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CHAT—Alzheimer's disease	3.98e-05	0.000614	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TPI1—Alzheimer's disease	3.98e-05	0.000614	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GAB2—Alzheimer's disease	3.92e-05	0.000604	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SST—Alzheimer's disease	3.92e-05	0.000604	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NTRK2—Alzheimer's disease	3.92e-05	0.000604	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CALM1—Alzheimer's disease	3.9e-05	0.000602	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GSK3A—Alzheimer's disease	3.88e-05	0.000599	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APP—Alzheimer's disease	3.82e-05	0.000589	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MAOB—Alzheimer's disease	3.81e-05	0.000589	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	3.67e-05	0.000567	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—F2—Alzheimer's disease	3.66e-05	0.000566	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.63e-05	0.00056	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PLCB1—Alzheimer's disease	3.6e-05	0.000556	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.6e-05	0.000555	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—A2M—Alzheimer's disease	3.55e-05	0.000547	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NGFR—Alzheimer's disease	3.36e-05	0.000518	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CREB1—Alzheimer's disease	3.34e-05	0.000515	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADAM10—Alzheimer's disease	3.28e-05	0.000506	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCL2—Alzheimer's disease	3.27e-05	0.000504	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.16e-05	0.000488	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—S100B—Alzheimer's disease	3.1e-05	0.000479	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	3.09e-05	0.000476	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	3.05e-05	0.000471	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IGF2—Alzheimer's disease	2.95e-05	0.000456	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	2.89e-05	0.000446	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	2.89e-05	0.000446	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IGF1R—Alzheimer's disease	2.86e-05	0.000441	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	2.84e-05	0.000438	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LPL—Alzheimer's disease	2.74e-05	0.000423	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MEF2C—Alzheimer's disease	2.71e-05	0.000419	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	2.69e-05	0.000415	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCG—Alzheimer's disease	2.66e-05	0.000411	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NGF—Alzheimer's disease	2.59e-05	0.0004	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	2.54e-05	0.000391	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	2.52e-05	0.000389	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.49e-05	0.000384	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	2.47e-05	0.000381	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	2.46e-05	0.000379	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	2.3e-05	0.000356	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOE—Alzheimer's disease	2.3e-05	0.000354	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LEP—Alzheimer's disease	2.3e-05	0.000354	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	2.27e-05	0.000351	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	2.19e-05	0.000338	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—F2—Alzheimer's disease	2.16e-05	0.000334	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.12e-05	0.000327	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.12e-05	0.000327	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.11e-05	0.000326	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	1.99e-05	0.000307	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	1.97e-05	0.000304	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—INS—Alzheimer's disease	1.96e-05	0.000303	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	1.93e-05	0.000298	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.93e-05	0.000298	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	1.9e-05	0.000293	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.74e-05	0.000268	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.72e-05	0.000265	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.62e-05	0.00025	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.62e-05	0.00025	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.6e-05	0.000247	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.47e-05	0.000227	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.46e-05	0.000225	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.45e-05	0.000224	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.41e-05	0.000217	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—INS—Alzheimer's disease	1.38e-05	0.000213	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.34e-05	0.000207	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.34e-05	0.000207	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.24e-05	0.000191	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.21e-05	0.000187	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.14e-05	0.000176	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.11e-05	0.000171	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	9.36e-06	0.000144	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	8.57e-06	0.000132	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	7.91e-06	0.000122	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	5.57e-06	8.59e-05	CbGpPWpGaD
